-
Semiconductor Partnership to Focus on Energy Technologies
Semiconductor Research Corporation, a university-research consortium for semiconductors and related technologies has established a $5 million industry-university partnership to bring new energy systems and technologies to the marketplace. Founding industry members include ABB, Applied Materials, Bosch, First Solar, IBM, Nexans and Tokyo Electron. The new Energy Research Initiative will team companies from semiconductors and related…
-
Financing Deals: 12 July 2010
Accuri Cytometers in Ann Arbor, Michigan completed a $6 million financing deal involving sale of preferred stock to a group of investors including Arboretum Ventures, Baird Venture Partners, Fidelity Biosciences, Flagship Ventures and the InvestMichigan! Program co-managed by Credit Suisse. The company plans to use the financing to expand its C6 brand cytometer into the…
-
Genzyme to Expand its Suburban Boston Campus
Genzyme Corporation, a biotech company in Cambridge, Massachusetts, plans to double the size of its manufacturing and research facilities in nearby Framingham, according to a story by Scott Van Voorhis in yesterday’s Boston Globe. The plan involves doubling the size of that facility and adding up to 1,000 new jobs, according to a company executive…
-
U.S. Venture Capital Fundraising Drops by Half
In the second quarter of 2010, 38 venture capital (VC) firms in the U.S. raised $1.9 billion, a decline of 49% compared to the first quarter of 2010 and the lowest level of financial commitments since the third quarter of 2003. These results were reported in a survey released today by National Capital Venture Association…
-
California Nanoparticle Ink Developer in Solar Cell Deal
Innovalight, in Sunnyvale, California, will supply its silicon ink based on nanotechnology for JA Solar, a Chinese manufacturer of high-efficiency solar energy cells. The two companies will also co-develop solar cells that promise higher power-conversion efficiency. JA Solar has pilot tested Innovalight’s silicon ink since May 2010. Full commercial production is expected to begin later…
-
USPTO Seeks Comments on Strategic Plan
The U.S. Patent and Trademark Office (USPTO) is asking the public for feedback on its draft strategic plan for fiscal years 2010-2015. The 77-page document describes the agency’s mission, vision, and strategic goals. As described on the USPTO Web site, “The plan as fully implemented will enhance and accelerate the innovation and job growth needed…
-
U.S. R&D Companies Employ 27 Million Worldwide
More than 27 million people worldwide worked at U.S. companies in 2008 that fund or conduct research and development, according to new statistics from the National Science Foundation (NSF). Solid majorities of the 27.1 million employees in those companies worked in the U.S. (68%) or for manufacturing companies (60%). In these companies, however, just under…
-
Financing deals, 8 July 2010
Calithera Biosciences in South San Francisco, California today announced completion of a Series A financing totaling $40 million. Series A financing involves early sale of stock to external investors, after initial seed capital. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital taking part. Calithera Biosciences…
-
Merck to Cut Workforce, Close Research and Manufacturing Sites
Merck & Co. in Whitehouse Station, New Jersey announced today a consolidation of its research and manufacturing operations, reducing its workforce 15 percent and closing eight research and eight manufacturing sites. The reductions in sites and workers are part of Merck’s integration of facilities with Schering-Plough, following its acquisition in November 2009. The company says…
-
Financing deals: 7 July 2010
Oragenics, Inc. in Tampa, Florida entered into a common stock purchase agreement with the Koski Family Limited Partnership (KFLP), the company’s largest shareholder. In the deal, Oragenics will sell KFLP 5 million shares of its common stock at $0.40 a share. KFLP will also cancel and exchange for equity a previous $1 million note it…